Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

GHITM Inhibitors

GHITM, or Growth Hormone Inducible Transmembrane Protein, is a protein whose function and importance in cellular processes have garnered interest in the scientific community. It is a transmembrane protein, meaning it spans the lipid bilayer of cells, typically allowing it to play roles in various cellular activities such as signaling, transport, or anchoring. The presence of the term "growth hormone inducible" in its name suggests its expression or function may be influenced by growth hormones, which are crucial regulators of various physiological processes including growth, metabolism, and development.

Inhibitors targeting GHITM aim to modulate its activity or expression. The rationale behind developing GHITM inhibitors can be diverse, depending on the specific cellular processes or pathways in which GHITM is involved. For instance, if GHITM facilitates a particular cellular signal transduction pathway, an inhibitor could be designed to prevent this, thereby modulating the outcome of that signaling pathway. The design of GHITM inhibitors requires an intricate understanding of the protein's structure and function. In-depth studies on GHITM's interactions, its conformational changes, and its binding sites can offer insights that guide the design of effective inhibitors. Additionally, it's essential to consider the broader cellular context. Since GHITM is a transmembrane protein, its interaction with the lipid bilayer and other adjacent proteins can influence its function and, consequently, the design and function of potential inhibitors. The exploration into GHITM inhibitors exemplifies the complexities and opportunities in targeting specific proteins to modulate cellular processes, highlighting the intricate interplay of molecular interactions that define cellular function.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$36.00
$149.00
11
(1)

An antimetabolite that inhibits DNA synthesis, potentially reducing GHITM expression indirectly.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

A histone deacetylase inhibitor that might modify chromatin structure and affect GHITM expression.

Tamoxifen

10540-29-1sc-208414
2.5 g
$256.00
18
(2)

An estrogen receptor modulator that could have off-target effects on other gene expressions, including GHITM.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

A compound affecting cellular differentiation, which might indirectly modulate GHITM expression.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$76.00
$255.00
18
(1)

Inhibits ribonucleotide reductase, potentially affecting DNA synthesis and indirectly GHITM expression.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

A tyrosine kinase inhibitor that might affect signaling pathways indirectly influencing GHITM expression.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$38.00
$58.00
$102.00
$202.00
8
(1)

An Hsp90 inhibitor that can affect multiple proteins and might indirectly modulate GHITM stability or expression.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

An inhibitor of protein synthesis, which could decrease GHITM protein levels.

Alsterpaullone

237430-03-4sc-202453
sc-202453A
1 mg
5 mg
$67.00
$306.00
2
(1)

A cyclin-dependent kinase inhibitor that might affect cell cycle progression and potentially GHITM expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that might modulate signaling pathways and indirectly affect GHITM expression.